Please login to the form below

Not currently logged in
Email:
Password:

Publicis Health makes senior UK promotions

Promotes staff across Publicis Life Brands, Resolute and Real Science

Publicis HealthPublicis Health has promoted four of its team members across three of its UK agencies as part of the group’s “commitment to attracting and nurturing outstanding talent”.

Among the promoted is Victoria Stanley (pictured top left) who is now an associate director of Publicis Resolute - the group’s PR and medical education agency - along with Zayn Qureshi (pictured top right) who has been promoted to senior account director.

Camilla Ross (pictured bottom left) - who joined Publicis Health in 2014 - also takes up a senior account director role but at the group’s advertising subsidiary Publicis LifeBrands.

Additionally, Nicole Corteen (pictured bottom right) has been promoted to senior medical writer at the group’s medical education agency Real Science.

Victoria Wright, managing director of all three agencies, said: “I’m so proud of Victoria, Camilla, Zayn and Nicole. They live and breath our agency ethos - extraordinary ideas, serious imagination and insatiable curiosity.

"Collectively they have over 20 years’ of loyal service and it has been an absolute pleasure watching them grow and develop over the years. I know they all have bright futures ahead of them at Publicis Health.”

27th July 2017

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics